A somatostatin analog improves tilt table tolerance by decreasing splanchnic vascular conductance

Sara S Jarvis, J. P. Florian, M. J. Curren, J. A. Pawelczyk

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Splanchnic hemodynamics and tilt table tolerance were assessed after an infusion of placebo or octreotide acetate, a somatostatin analog whose vascular effects are largely confined to the splanchnic circulation. We hypothesized that reductions in splanchnic blood flow (SpBF) and splanchnic vascular conductance (SpVC) would be related to improvements in tilt table tolerance. In randomized, double-blind, crossover trials, hemodynamic variables were collected in 14 women and 16 men during baseline, 70° head-up tilt (HUT), and recovery. A repeated-measures analysis of variance was used to compare changes from baseline with respect to sex and condition. HUT elicited an increase in heart rate and decreases in mean arterial pressure, cardiac index, stroke index, and systemic vascular conductance. Additionally, SpVC and non-SpVC were lower during HUT. Octreotide reduced SpBF and SpVC and increased systemic vascular conductance and non-SpVC. Changes in SpBF and SpVC between supine and HUT were smaller in women (P < 0.05). Tilt table tolerance was increased after administration of octreotide [median tilt time: 15.7 vs. 37.0 min (P < 0.05) and 21.8 vs. 45.0 min (P < 0.05) for women and men, respectively]. A significant relationship existed between change (Δ) in SpBF (placebo-octreotide) and Δtilt time in women (Δtilt time = 2.5- 0.0083 ΔSpBF, P < 0.01), but not men (Δtilt time = 3.41- 0.0008 ΔSpBF, P = 0.59). In conclusion, administration of octreotide acetate improved tilt table tolerance, which was associated with a decrease in SpVC. In women, but not men, the magnitude of reduction in SpBF was positively associated with improvements in tilt tolerance.

Original languageEnglish (US)
Pages (from-to)1504-1511
Number of pages8
JournalJournal of Applied Physiology
Volume112
Issue number9
DOIs
StatePublished - May 1 2012
Externally publishedYes

Fingerprint

Viscera
Somatostatin
Blood Vessels
Octreotide
Head
Hemodynamics
Placebos
Splanchnic Circulation
Cross-Over Studies
Analysis of Variance
Arterial Pressure

Keywords

  • Octreotide
  • Orthostatic intolerance
  • Splanchnic blood flow

ASJC Scopus subject areas

  • Physiology
  • Physiology (medical)

Cite this

A somatostatin analog improves tilt table tolerance by decreasing splanchnic vascular conductance. / Jarvis, Sara S; Florian, J. P.; Curren, M. J.; Pawelczyk, J. A.

In: Journal of Applied Physiology, Vol. 112, No. 9, 01.05.2012, p. 1504-1511.

Research output: Contribution to journalArticle

Jarvis, Sara S ; Florian, J. P. ; Curren, M. J. ; Pawelczyk, J. A. / A somatostatin analog improves tilt table tolerance by decreasing splanchnic vascular conductance. In: Journal of Applied Physiology. 2012 ; Vol. 112, No. 9. pp. 1504-1511.
@article{65409603087c486db27048e82966121d,
title = "A somatostatin analog improves tilt table tolerance by decreasing splanchnic vascular conductance",
abstract = "Splanchnic hemodynamics and tilt table tolerance were assessed after an infusion of placebo or octreotide acetate, a somatostatin analog whose vascular effects are largely confined to the splanchnic circulation. We hypothesized that reductions in splanchnic blood flow (SpBF) and splanchnic vascular conductance (SpVC) would be related to improvements in tilt table tolerance. In randomized, double-blind, crossover trials, hemodynamic variables were collected in 14 women and 16 men during baseline, 70° head-up tilt (HUT), and recovery. A repeated-measures analysis of variance was used to compare changes from baseline with respect to sex and condition. HUT elicited an increase in heart rate and decreases in mean arterial pressure, cardiac index, stroke index, and systemic vascular conductance. Additionally, SpVC and non-SpVC were lower during HUT. Octreotide reduced SpBF and SpVC and increased systemic vascular conductance and non-SpVC. Changes in SpBF and SpVC between supine and HUT were smaller in women (P < 0.05). Tilt table tolerance was increased after administration of octreotide [median tilt time: 15.7 vs. 37.0 min (P < 0.05) and 21.8 vs. 45.0 min (P < 0.05) for women and men, respectively]. A significant relationship existed between change (Δ) in SpBF (placebo-octreotide) and Δtilt time in women (Δtilt time = 2.5- 0.0083 ΔSpBF, P < 0.01), but not men (Δtilt time = 3.41- 0.0008 ΔSpBF, P = 0.59). In conclusion, administration of octreotide acetate improved tilt table tolerance, which was associated with a decrease in SpVC. In women, but not men, the magnitude of reduction in SpBF was positively associated with improvements in tilt tolerance.",
keywords = "Octreotide, Orthostatic intolerance, Splanchnic blood flow",
author = "Jarvis, {Sara S} and Florian, {J. P.} and Curren, {M. J.} and Pawelczyk, {J. A.}",
year = "2012",
month = "5",
day = "1",
doi = "10.1152/japplphysiol.01475.2010",
language = "English (US)",
volume = "112",
pages = "1504--1511",
journal = "Journal of Applied Physiology Respiratory Environmental and Exercise Physiology",
issn = "8750-7587",
publisher = "American Physiological Society",
number = "9",

}

TY - JOUR

T1 - A somatostatin analog improves tilt table tolerance by decreasing splanchnic vascular conductance

AU - Jarvis, Sara S

AU - Florian, J. P.

AU - Curren, M. J.

AU - Pawelczyk, J. A.

PY - 2012/5/1

Y1 - 2012/5/1

N2 - Splanchnic hemodynamics and tilt table tolerance were assessed after an infusion of placebo or octreotide acetate, a somatostatin analog whose vascular effects are largely confined to the splanchnic circulation. We hypothesized that reductions in splanchnic blood flow (SpBF) and splanchnic vascular conductance (SpVC) would be related to improvements in tilt table tolerance. In randomized, double-blind, crossover trials, hemodynamic variables were collected in 14 women and 16 men during baseline, 70° head-up tilt (HUT), and recovery. A repeated-measures analysis of variance was used to compare changes from baseline with respect to sex and condition. HUT elicited an increase in heart rate and decreases in mean arterial pressure, cardiac index, stroke index, and systemic vascular conductance. Additionally, SpVC and non-SpVC were lower during HUT. Octreotide reduced SpBF and SpVC and increased systemic vascular conductance and non-SpVC. Changes in SpBF and SpVC between supine and HUT were smaller in women (P < 0.05). Tilt table tolerance was increased after administration of octreotide [median tilt time: 15.7 vs. 37.0 min (P < 0.05) and 21.8 vs. 45.0 min (P < 0.05) for women and men, respectively]. A significant relationship existed between change (Δ) in SpBF (placebo-octreotide) and Δtilt time in women (Δtilt time = 2.5- 0.0083 ΔSpBF, P < 0.01), but not men (Δtilt time = 3.41- 0.0008 ΔSpBF, P = 0.59). In conclusion, administration of octreotide acetate improved tilt table tolerance, which was associated with a decrease in SpVC. In women, but not men, the magnitude of reduction in SpBF was positively associated with improvements in tilt tolerance.

AB - Splanchnic hemodynamics and tilt table tolerance were assessed after an infusion of placebo or octreotide acetate, a somatostatin analog whose vascular effects are largely confined to the splanchnic circulation. We hypothesized that reductions in splanchnic blood flow (SpBF) and splanchnic vascular conductance (SpVC) would be related to improvements in tilt table tolerance. In randomized, double-blind, crossover trials, hemodynamic variables were collected in 14 women and 16 men during baseline, 70° head-up tilt (HUT), and recovery. A repeated-measures analysis of variance was used to compare changes from baseline with respect to sex and condition. HUT elicited an increase in heart rate and decreases in mean arterial pressure, cardiac index, stroke index, and systemic vascular conductance. Additionally, SpVC and non-SpVC were lower during HUT. Octreotide reduced SpBF and SpVC and increased systemic vascular conductance and non-SpVC. Changes in SpBF and SpVC between supine and HUT were smaller in women (P < 0.05). Tilt table tolerance was increased after administration of octreotide [median tilt time: 15.7 vs. 37.0 min (P < 0.05) and 21.8 vs. 45.0 min (P < 0.05) for women and men, respectively]. A significant relationship existed between change (Δ) in SpBF (placebo-octreotide) and Δtilt time in women (Δtilt time = 2.5- 0.0083 ΔSpBF, P < 0.01), but not men (Δtilt time = 3.41- 0.0008 ΔSpBF, P = 0.59). In conclusion, administration of octreotide acetate improved tilt table tolerance, which was associated with a decrease in SpVC. In women, but not men, the magnitude of reduction in SpBF was positively associated with improvements in tilt tolerance.

KW - Octreotide

KW - Orthostatic intolerance

KW - Splanchnic blood flow

UR - http://www.scopus.com/inward/record.url?scp=84862080639&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862080639&partnerID=8YFLogxK

U2 - 10.1152/japplphysiol.01475.2010

DO - 10.1152/japplphysiol.01475.2010

M3 - Article

C2 - 22345429

AN - SCOPUS:84862080639

VL - 112

SP - 1504

EP - 1511

JO - Journal of Applied Physiology Respiratory Environmental and Exercise Physiology

JF - Journal of Applied Physiology Respiratory Environmental and Exercise Physiology

SN - 8750-7587

IS - 9

ER -